Lenalidomide Reference Standards & Impurities | Simson Pharma Private Limited

Lenalidomide Related Compounds & Impurities

Lenalidomide is a thalidomide analogue immunomodulatory drug with direct antitumour and immune-enhancing effects, used for multiple myeloma, MDS and mantle cell lymphoma.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Lenalidomide reference standards, pharmacopeial and non-pharmacopeial Lenalidomide impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Lenalidomide-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Impurity Standards

(3-(1-oxo-4-((e) ((3R,4R)-2,3,5,6-tetrahydroxy-4-((S, 3R, 4R,5R)-3,4,5-tri-hydroxy-6-(hydroxymethyl)tetrahydro-2hpyran-2-yloxy)hexyli-dene)amino)isoindolin-2-yl)piperidine-2,6-dione)

CAT. No.L260061 CAS No.NA Mol. F.C25H33N3O13 Mol. W.583.54 g/mol Stock Status Custom Synthesis

COA MSDS

2-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)pentanedioic acid

CAT. No.L260012 CAS No.295357-66-3 Mol. F.C13H14N2O5 Mol. W.278.26 g/mol Stock Status Custom Synthesis

COA MSDS

2-(4-amino-1-oxoisoindolin-2-yl)pentanediamide

CAT. No.L260025 CAS No.2197414-55-2 Mol. F.C13H16N4O3 Mol. W.276.29 g/mol Stock Status Instock

COA MSDS

2-methyl-5-nitro-benzoic acid methyl ester

CAT. No.L260047 CAS No.77324-87-9 Mol. F.C9H9NO4 Mol. W.195.17 g/mol Stock Status Instock

COA MSDS

2-Methyl-5-nitrobenzoic acid

CAT. No.L260056 CAS No.1975-52-6 Mol. F.C8H7NO4 Mol. W.181.15 g/mol Stock Status Custom Synthesis

COA MSDS

2-methyl-6-nitro benzoic acid methyl ester

CAT. No.L260048 CAS No.61940-22-5 Mol. F.C9H9NO4 Mol. W.195.17 g/mol Stock Status Instock

COA MSDS

2H-Isoindole-2-butanoicacid,4-amino-gamma-(aminocarbonyl)-1,3-dihydro-1-oxo-,(gammaS)

CAT. No.L260065 CAS No.874760-72-2 Mol. F.C13H15N3O4 Mol. W.277.28 g/mol Stock Status Custom Synthesis

COA MSDS

3-(1-oxo-4-((z) -((3R,4R)-2,3,5,6-tetrahydroxy-4-((S, 3R,4R, 5R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2hpyran-2-yloxy)hexyli-dene)amino)isoindolin-2-yl)piperidine-2,6-dione

CAT. No.L260062 CAS No.NA Mol. F.C25H33N3O13 Mol. W.583.54 g/mol Stock Status Custom Synthesis

COA MSDS

3-amino piperdine-2,6-dion Hydrochloride

CAT. No.L260009 CAS No.24666-56-6/2686-86-4 Mol. F.C5H8N2O2·HCl Mol. W.164.59 g/mol Stock Status Instock

COA MSDS

3-methyl-2-nitro benzoic acid methyl ester

CAT. No.L260050 CAS No.5471-82-9 Mol. F.C9H9NO4 Mol. W.195.17 g/mol Stock Status Instock

COA MSDS

4-amino-a-(3-amino-3-oxopropyl)1,3-dihydro-1-oxo-2H-Isoindole-2-aceticacidmethylester

CAT. No.L260038 CAS No.878782-79-7 Mol. F.C14H17N3O4 Mol. W.321.29 g/mol Stock Status Custom Synthesis

COA MSDS

4-methyl-3-nitrobenzoic acid methyl ester

CAT. No.L260049 CAS No.7356-11-8 Mol. F.C9H9NO4 Mol. W.195.17 g/mol Stock Status Custom Synthesis

COA MSDS

4-Nitro Lenalidomide

CAT. No.L260031 CAS No.827026-45-9 Mol. F.C13H11N3O5 Mol. W.289.24 g/mol Stock Status Custom Synthesis

COA MSDS

4-Nitrophthalide

CAT. No.L260051 CAS No.65399-18-0 Mol. F.C8H5NO4 Mol. W.179.13 g/mol Stock Status Custom Synthesis

COA MSDS

5-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid

CAT. No.L260040 CAS No.1198299-72-7 Mol. F.C13H13N3O6 Mol. W.307.26 g/mol Stock Status Custom Synthesis

COA MSDS

5-Hydroxy Lenalidomide

CAT. No.L260016 CAS No.1421593-78-3 Mol. F.C13H13N3O4 Mol. W.275.26 g/mol Stock Status Custom Synthesis

COA MSDS

Glutamic Anhydride

CAT. No.L260054 CAS No.6810-78-2 Mol. F.C5H7NO3 Mol. W.129.11 g/mol Stock Status Custom Synthesis

COA MSDS

L-Glutamic Anhydride Hydrochloride

CAT. No.L260036 CAS No.48103-74-8(FreeBase) Mol. F.C5H7NO3.HCl Mol. W.165.57 g/mol Stock Status Custom Synthesis

COA MSDS

L-Glutamine tert-Butyl Ester Hydrochloride

CAT. No.L260013 CAS No.39741-62-3 Mol. F.C9H18N2O3HCl Mol. W.238.71 g/mol Stock Status Custom Synthesis

COA MSDS

Lenalidomide (Form H1)

CAT. No.L260063 CAS No.191732-72-6 Mol. F.C13H13N3O3 Mol. W.259.26 g/mol Stock Status Custom Synthesis

COA MSDS

Lenalidomide 5-Hydroxy Impurity

CAT. No.L260023 CAS No.1421593-78-3 Mol. F.C13H13N3O4 Mol. W.275.26 g/mol Stock Status Instock

COA MSDS

Lenalidomide Crystal form A

CAT. No.L260019 CAS No.191732-72-6 Mol. F.C13H13N3O3 Mol. W.259.26 g/mol Stock Status Custom Synthesis

COA MSDS

Lenalidomide Dimethyl sulphoxide

CAT. No.L260075 CAS No.2083617-58-5 Mol. F.C13H13N3O3.C2H6OS Mol. W.337.39 g/mol Stock Status Custom Synthesis

COA MSDS

Working Standards

Lenalidomide

CAT. No.L260000 CAS No.191732-72-6 Mol. F.C13H13N3O3 Mol. W.259.26 g/mol Stock Status Instock

COA MSDS

Search products

Lenalidomide Related Compounds & Impurities

Impurity Standards

(3-(1-oxo-4-((e) ((3R,4R)-2,3,5,6-tetrahydroxy-4-((S, 3R, 4R,5R)-3,4,5-tri-hydroxy-6-(hydroxymethyl)tetrahydro-2hpyran-2-yloxy)hexyli-dene)amino)isoindolin-2-yl)piperidine-2,6-dione)

2-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)pentanedioic acid

2-(4-amino-1-oxoisoindolin-2-yl)pentanediamide

2-methyl-5-nitro-benzoic acid methyl ester

2-Methyl-5-nitrobenzoic acid

2-methyl-6-nitro benzoic acid methyl ester

2H-Isoindole-2-butanoicacid,4-amino-gamma-(aminocarbonyl)-1,3-dihydro-1-oxo-,(gammaS)

3-(1-oxo-4-((z) -((3R,4R)-2,3,5,6-tetrahydroxy-4-((S, 3R,4R, 5R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2hpyran-2-yloxy)hexyli-dene)amino)isoindolin-2-yl)piperidine-2,6-dione

3-amino piperdine-2,6-dion Hydrochloride

3-methyl-2-nitro benzoic acid methyl ester

4-amino-a-(3-amino-3-oxopropyl)1,3-dihydro-1-oxo-2H-Isoindole-2-aceticacidmethylester

4-methyl-3-nitrobenzoic acid methyl ester

4-Nitro Lenalidomide

4-Nitrophthalide

5-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid

5-Hydroxy Lenalidomide

Glutamic Anhydride

L-Glutamic Anhydride Hydrochloride

L-Glutamine tert-Butyl Ester Hydrochloride

Lenalidomide (Form H1)

Lenalidomide 5-Hydroxy Impurity

Lenalidomide Crystal form A

Lenalidomide Dimethyl sulphoxide

Working Standards

Lenalidomide

Product structure

Sample structure